PART I (Cont'd) 
Pane Three 
Attachment IV - Page 7 
3. It was the general consensus that cell fusion not be 
subject to addition al re g Ulat-imi ulUer than standa rds no w 
applicable for basic laboratory researc h. It was a consensus 
that there was no need tor further oversight or regulation. 
4. In connection with the clinical application of hum an 
gene therapy , and related activities , that such activity remai n 
within the primary authority ot nih-kac. 
5. It was a consensus recommendation that the NIH-RAC 
continue to be the lead agency in determining the risk asses s- 
ment for R-DNA laboratory research activity. 
6. It was a further consensus that laboratory procedure 
and all applicable provisions and procedures remain within the 
primary province of NIH-RAC, and that no other agency would be 
able, by its actions, to change, modify or alter such laboratory 
research standards and practices. That the establishment of any 
new mechanism would not place upon laboratory research any addi- 
tional oversight. 
[ 417 ] 
